Big Pharma Split Corp.
PRM.TO
TSX
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.16M | 1.18M | 154.60K | 150.90K | 300.20K |
| Total Receivables | 44.90K | 45.40K | 58.40K | 57.00K | 65.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.80K | 31.10K | 543.90K | 530.90K | 289.90K |
| Total Current Assets | 1.24M | 1.25M | 756.90K | 738.90K | 655.90K |
|
|
|||||
| Total Current Assets | 1.24M | 1.25M | 756.90K | 738.90K | 655.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 20.20M | 20.42M | 20.09M | 19.62M | 21.02M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.83M | 7.92M | 7.80M | 7.61M | 7.54M |
| Total Finance Division Other Current Liabilities | 810.60K | 819.30K | 292.40K | 285.50K | 289.30K |
| Total Other Current Liabilities | 810.60K | 819.30K | 292.40K | 285.50K | 289.30K |
| Total Current Liabilities | 8.64M | 8.73M | 8.09M | 7.90M | 7.83M |
|
|
|||||
| Total Current Liabilities | 8.64M | 8.73M | 8.09M | 7.90M | 7.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.64M | 8.73M | 8.09M | 7.90M | 7.83M |
|
|
|||||
| Common Stock & APIC | 11.56M | 11.68M | 12.00M | 11.72M | 13.19M |
| Retained Earnings | -- | -- | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 11.56M | 11.68M | 12.00M | 11.72M | 13.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.56M | 11.68M | 12.00M | 11.72M | 13.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.56M | 11.68M | 12.00M | 11.72M | 13.19M |
|
|
|||||
